Product Information

BUPROPION HCL XL 300 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.0982 per EA under NDC 50228014530. Its NADAC has been published 323 times since Sep 9, 2020.

FDA first approved this application on Apr 12, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 300 MG TABLET

bupropion hydrochloride
$0.0982per EA

Strength

300 mg/1

NDC

50228014530

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207479

FDA Approved

4/12/2017

TE Code

AB3

On Market Since

4/12/2017

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 300 MG TABLET has been published 323 times since Sep 9, 2020, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0982 per EA
All-time high$0.2793 (Oct 14, 2020)
All-time low$0.0982 (Oct 21, 2026)
52-week high$0.1385
52-week low$0.0982
Median price$0.1624
Average price$0.1653
Largest weekly change-27.4% (Feb 21, 2024)
Weeks tracked323
Tracking sinceSep 9, 2020

Price History

1W

0.0%

1M

-2.3%

3M

-5.7%

6M

-11.0%

1Y

-32.0%

3Y

-47.8%

5Y

-46.4%

All

-57.3%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 300 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.0982 per EA (NDC 50228014530), effective Nov 11, 2026.

How has the price of BUPROPION HCL XL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 300 MG TABLET has declined 57.3%. It has been tracked across 323 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 300 MG TABLET?

Since Sep 9, 2020, the NADAC for BUPROPION HCL XL 300 MG TABLET has ranged from a low of $0.0982 (Oct 21, 2026) to a high of $0.2793 (Oct 14, 2020), with a median of $0.1624 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 300 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 300 MG TABLET?

BUPROPION HCL XL 300 MG TABLET (NDC 50228014530) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.